123 related articles for article (PubMed ID: 29710490)
1. Anti-metastatic potential of a proton beam is regulated by p38 MAPK/c-Fos signaling pathway in TPA-treated HepG2 human hepatocellular carcinoma.
Chun SY; Kim S; Nam KS; Lee KS
Biomed Pharmacother; 2018 Mar; 99():904-912. PubMed ID: 29710490
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
[TBL] [Abstract][Full Text] [Related]
3. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
Pan MH; Chiou YS; Chen WJ; Wang JM; Badmaev V; Ho CT
Carcinogenesis; 2009 Jul; 30(7):1234-42. PubMed ID: 19447859
[TBL] [Abstract][Full Text] [Related]
5. Anti-invasion and anti-metastasis effects of Valjatrate E via reduction of matrix metalloproteinases expression and suppression of MAPK/ERK signaling pathway.
Sun Y; Lan M; Chen X; Dai Y; Zhao X; Wang L; Zhao T; Li Y; Zhu J; Zhang X; Jiang H; Wu X; Chen C; Zhang T; Yan Z
Biomed Pharmacother; 2018 Aug; 104():817-824. PubMed ID: 29703569
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
[TBL] [Abstract][Full Text] [Related]
7. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
9. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
Hwang ES; Lee HJ
Food Chem Toxicol; 2008 Jul; 46(7):2358-64. PubMed ID: 18502015
[TBL] [Abstract][Full Text] [Related]
10. Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells.
Ye JC; Hsieh YS; Chen PN; Liu JY; Hsieh YH
Drug Dev Res; 2023 Jun; 84(4):767-776. PubMed ID: 37005497
[TBL] [Abstract][Full Text] [Related]
11. Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway.
Lee KS; Lee DH; Chun SY; Nam KS
Mol Med Rep; 2014 Aug; 10(2):1007-12. PubMed ID: 24859472
[TBL] [Abstract][Full Text] [Related]
12. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways.
Huang GJ; Yang CM; Chang YS; Amagaya S; Wang HC; Hou WC; Huang SS; Hu ML
J Agric Food Chem; 2010 Sep; 58(17):9468-75. PubMed ID: 20698552
[TBL] [Abstract][Full Text] [Related]
13. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
Liu WH; Chang LS
J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
[TBL] [Abstract][Full Text] [Related]
14. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
15. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
16. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
17. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma.
Wang N; Zhu M; Tsao SW; Man K; Zhang Z; Feng Y
PLoS One; 2012; 7(9):e46318. PubMed ID: 23029478
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
20. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
